Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease
暂无分享,去创建一个
Katharigatta N Venugopala | Mahmoud A A Ibrahim | Alaa H M Abdelrahman | K. N. Venugopala | K. Oh-hashi | Mahmoud A. A. Ibrahim | M. Morsy | Mahmoud Kandeel | M. Kandeel | Alaa H. M. Abdelrahman | A. Ibrahim | Kentaro Oh-Hashi | Abdelazim Ibrahim | Mohamed A Morsy | K. Oh‐hashi | K. Venugopala
[1] Hyun Young Shin,et al. The Author's Response: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR. , 2020, Journal of Korean medical science.
[2] Byoung Kwon Park,et al. Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers , 2020, Biomolecules & therapeutics.
[3] T. Darden,et al. Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .
[4] R. Baric,et al. Coronavirus Genome Structure and Replication , 2005, Current topics in microbiology and immunology.
[5] C. Simmerling,et al. ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. , 2015, Journal of chemical theory and computation.
[6] Jiandong Shi,et al. Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases , 2015, PloS one.
[7] John Bechill,et al. Identification of Severe Acute Respiratory Syndrome Coronavirus Replicase Products and Characterization of Papain-Like Protease Activity , 2004, Journal of Virology.
[8] M. Kandeel,et al. Molecular Dynamic Studies of Interferon and Innate Immunity Resistance in MERS CoV Non-Structural Protein 3. , 2017, Biological & pharmaceutical bulletin.
[9] Hege S. Beard,et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.
[10] John E Kerrigan,et al. Molecular dynamics simulations in drug design. , 2013, Methods in molecular biology.
[11] A. Cavalli,et al. Role of Molecular Dynamics and Related Methods in Drug Discovery. , 2016, Journal of medicinal chemistry.
[12] J. Y. Kim. Letter to the Editor: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR , 2020, Journal of Korean medical science.
[13] B. Bailey-Elkin,et al. Crystal structure of the Middle-East respiratory syndrome coronavirus papain-like protease , 2014 .
[14] P. Kollman,et al. Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding , 2000 .
[15] M. Kandeel,et al. Molecular Dynamics and Inhibition of MERS CoV Papain-like Protease by Small Molecule Imidazole and Aminopurine Derivatives , 2019, Letters in Drug Design & Discovery.
[16] A. Mesecar,et al. The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds , 2014, Antiviral Research.
[17] A. Mesecar,et al. Catalytic Function and Substrate Specificity of the Papain-Like Protease Domain of nsp3 from the Middle East Respiratory Syndrome Coronavirus , 2014, Journal of Virology.
[18] Gaoxue Wang,et al. Effects of moroxydine hydrochloride and ribavirin on the cellular growth and immune responses by inhibition of GCRV proliferation. , 2018, Research in veterinary science.
[19] Arvind H. Patel,et al. Rethinking the old antiviral drug moroxydine: Discovery of novel analogues as anti-hepatitis C virus (HCV) agents. , 2015, Bioorganic & medicinal chemistry letters.
[20] Mahmoud Kandeel,et al. Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease , 2020, Life Sciences.
[21] Kiira Ratia,et al. Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating Activity of SARS-CoV Papain-Like Protease , 2014, PLoS pathogens.
[22] H. Berendsen,et al. Molecular dynamics with coupling to an external bath , 1984 .
[23] Zhongbin Chen,et al. Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease. , 2014, The Journal of general virology.
[24] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[25] Jianguo Wu,et al. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS‐CoV‐2 , 2020, Journal of medical virology.
[26] Jaegyun Lim,et al. Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR , 2020, Journal of Korean medical science.
[27] Brian L. Mark,et al. Crystal Structure of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Papain-like Protease Bound to Ubiquitin Facilitates Targeted Disruption of Deubiquitinating Activity to Demonstrate Its Role in Innate Immune Suppression , 2014, The Journal of Biological Chemistry.
[28] M. Kandeel,et al. Synonymous and Biased Codon Usage by MERS CoV Papain-Like and 3CL-Proteases. , 2017, Biological & pharmaceutical bulletin.
[29] Gaoxue Wang,et al. Moroxydine hydrochloride inhibits grass carp reovirus replication and suppresses apoptosis in Ctenopharyngodon idella kidney cells. , 2016, Antiviral research.
[30] G. Drusano,et al. Oseltamivir‐zanamivir combination therapy suppresses drug‐resistant H1N1 influenza A viruses in the hollow fiber infection model (HFIM) system , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[31] C. Perry,et al. Lopinavir/Ritonavir , 2010, Drugs.
[32] M. Kandeel,et al. From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes , 2020, Journal of medical virology.
[33] A. Mesecar,et al. MERS-CoV papain-like protease has deISGylating and deubiquitinating activities , 2013, Virology.
[34] P. Kollman,et al. A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .
[35] R. Hilgenfeld,et al. Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features , 2014, Antiviral Research.
[36] J. Guarner. Three Emerging Coronaviruses in Two Decades , 2020, American journal of clinical pathology.
[37] Yao Yu,et al. Multivalent zanamivir-bovine serum albumin conjugate as a potent influenza neuraminidase inhibitor , 2017 .